Volume-wise, France has been in the top 5 ODA donors over the past years. According to the DAC, ODA represented 0.37% of its GNI in 2014 and 2015 (respectively €8 billion and €8.15 billion in volume).
According to our methodology, France allocated €1.118 billion and €906 million to global health in 2014 and 2015, which respectively represented 0.046% and 0.036% of its GNI; far from the recommendation of the WHO Commission on Macroeconomics and Health, and below the performance of the UK.
However the relatively good performance in 2014 was mainly due to a substantive loan to reform the health sector in Colombia. In 2015, the ratio decreased sharply and plummeted to its lowest level since 2007.
14% of overall ODA was dedicated to DAH (Development Assistance for Health)
in 2014 and 12% in 2015. The ratio has remained the same since 2007 in average.
The Global Fund to Fight AIDS, Tuberculosis and Malaria is the main recipient of multilateral ODA (49%), followed by the European Union and UNITAID (respectively 20% and 12.5%).
We also noticed a misreporting of the Gavi contributions: first being reported as bilateral into the CRS databases, then not being consistent with the amount in the French budget bills. This could have biased the ranking.
As a consequence of the massive loan allocated to Colombia in 2014, France has channelled the majority of its bilateral DAH to upper-middle-income countries: 59% in 2014 against 21% for lower-income countries. In 2015, the situation reversed: 32.5% was allotted to lower-income countries.
Since the CRS database does not allow providing multiple recipients for one activity, all the multi-countries or multi-regions projects are reported as “unspecified”.
It’s worth noting that in 2014, 11% of the projects were unallocable by income groups, up to 36% in 2015. This could bias the analysis.